SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-053353
Filing Date
2020-04-29
Accepted
2020-04-29 16:06:02
Documents
14
Period of Report
2020-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018041-1_8k.htm   iXBRL 8-K 25298
2 EXHIBIT 99.1 tm2018041d1_ex99-1.htm EX-99.1 78095
6 GRAPHIC tm2018041d1_ex99-1img001.jpg GRAPHIC 2205
  Complete submission text file 0001104659-20-053353.txt   290705

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inva-20200429.xsd EX-101.SCH 3174
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20200429_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20200429_pre.xml EX-101.PRE 22702
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2018041-1_8k_htm.xml XML 3608
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 20830260
SIC: 2834 Pharmaceutical Preparations